Phothera® Announces Newly Formed Scientific Advisory Board to Lead Innovations in Phototherapy

Phothera® Strengthens Dermatology with New Scientific Advisory Board



Phothera®, an eminent manufacturer known for its FDA-cleared at-home and clinical phototherapy devices, has made a significant announcement regarding its 2026-2027 Scientific Advisory Board. This newly established advisory body features a diverse group of seven distinguished experts in dermatology and phototherapy, who will provide critical clinical guidance in areas such as NB-UVB (narrowband ultraviolet B) phototherapy, physician education, research directions, and enhancing access to treatments for chronic skin conditions like vitiligo, psoriasis, atopic dermatitis, and cutaneous T-cell lymphoma.

Leadership and Expertise


Chaired by Dr. Raja Sivamani, who serves both as a Consultant and Acting Chief Medical Officer at Phothera, the Board is composed of leading authorities in inflammatory skin diseases and complex medical dermatology. Each member brings a wealth of experience from prestigious professional organizations and clinical research initiatives, thus contributing to the advancement of dermatologic care and phototherapy. Dr. Austin Monroe, Phothera's Vice President of Marketing, emphasized the significance of this assembly of expertise, noting that as dermatological treatments evolve, there exists a pressing need to fortify the efficacy of phototherapy through advocacy, education, and collaboration with physicians.

Meet the Board Members


  • - Dr. Raja Sivamani, MD, MS, AP: An expert in dermatologic therapeutics and a longstanding advisor to Phothera, Dr. Sivamani is based in Sacramento, CA, and focuses on inflammatory skin conditions.
  • - Dr. Seemal R. Desai, MD, FAAD: Serving as the President of the Global Vitiligo Foundation, this Dallas-based dermatologist is recognized for his leadership in vitiligo and pigmentary disorders.
  • - Dr. Nada Elbuluk, MD, MSc, FAAD: A professor at USC's Keck School of Medicine, she is a pioneer in skin of color dermatology and health equity, based in Los Angeles, CA.
  • - Dr. Pearl E. Grimes, MD, FAAD: Founder of the Vitiligo Pigmentation Institute and an influential figure in clinical research, she practices in Los Angeles, CA.
  • - Dr. Iltefat H. Hamzavi, MD, FAAD: Co-founder of the Global Vitiligo Foundation and recipient of the John Kenney Lifetime Achievement Award, he specializes in photomedicine and vitiligo.
  • - Dr. Nicholas K. Mollanazar, MD, MBA: A clinical professor at the University of Pennsylvania, he directs patient access and excels in complex medical dermatology.
  • - Dr. Eingun James Song, MD, FAAD: Chief Medical Officer at Frontier Dermatology, this Mill Creek, WA-based expert focuses on chronic inflammatory skin diseases.

Evolving Role of At-Home Phototherapy


Narrowband UVB phototherapy is a well-established, non-drug approach utilized to treat multiple chronic skin conditions. This method can be administered in a clinical setting or through at-home devices prescribed by healthcare providers. The new Scientific Advisory Board is tasked with identifying key research priorities, advancing physician education, and facilitating an expanded understanding of NB-UVB phototherapy.

One crucial area of focus will be the evolving role of at-home phototherapy, which aims to lessen the treatment burden associated with frequent visits to clinics. The Board will examine how to overcome barriers to its adoption and explore synergies between phototherapy and emerging treatments, all while striving to enhance the field with innovative research and technological advancements. The Board's meetings will occur quarterly, with contributions directed towards scientific discourse, educational initiatives, and clinical projects aimed at elevating patient care standards.

About Phothera®


With over 80 years of combined expertise, Phothera stands as a reputable entity within Madison Industries, striving to improve access to proven phototherapy methods for individuals grappling with chronic skin disabilities. As a vanguard of FDA-approved home and clinical NB-UVB solutions, Phothera is dedicated to empowering both patients and healthcare providers in navigating treatment pathways through reliable technology, modernized solutions, unwavering support, and an extensive array of targeted devices. For additional information, please visit www.phothera.com.

Topics Health)

【About Using Articles】

You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.

【About Links】

Links are free to use.